<DOC>
	<DOCNO>NCT01911364</DOCNO>
	<brief_summary>The purpose study determine triple combination beclometasone dipropionate+Formoterol fumarate+Glycopyrrolate bromide effective treatment severe COPD patient ( chronic obstructive pulmonary disease )</brief_summary>
	<brief_title>Efficacy Fixed Combination Beclometasone + Formoterol + Glycopyrrolate Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description>A 52-WEEK , DOUBLE BLIND , DOUBLE DUMMY , RANDOMIZED , 3-ARM PARALLEL GROUP , ACTIVE CONTROLLED CLINICAL TRIAL OF FIXED COMBINATION OF BECLOMETASONE DIPROPIONATE PLUS FORMOTEROL FUMARATE PLUS GLYCOPYRROLATE BROMIDE ADMINISTERED VIA PMDI ( CHF 5993 ) VERSUS TIOTROPIUM BROMIDE AND VERSUS FIXED COMBINATION OF BECLOMETASONE DIPROPIONATE PLUS FORMOTEROL FUMARATE ADMINISTERED VIA PMDI AND TIOTROPIUM BROMIDE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE A total 8 clinic visit ( V0 V7 ) perform study , follow : - A pre-screening visit ( V0 ) obtain write informed consent patient - A screening visit ( V1 ) establish eligibility patient , follow 2-week open-label run-in Tiotropium - After randomisation ( V2 ) , patient assess 4 , 12 , 26 , 40 52 week treatment ( V3 V7 ) The assessment perform visit include routine haematology blood chemistry , medical history , physical examination , 12-lead ECG , spirometric parameter , vital sign ) . During run-in randomised treatment period , patient use e-diary record symptom , rescue medication use compliance study medication daily . AEs/SAEs COPD exacerbation monitor .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Glycopyrrolate</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Beclomethasone</mesh_term>
	<criteria>Male female COPD patient age ≥ 40 year Current smoker exsmokers FEV1 &lt; 50 % predict ( FEV1/FVC &lt; 0,7 ) least 1 documented exacerbation last 12 Mo Pregnant lactate woman woman physiologically capable become pregnant Diagnosis asthma , history allergic rhinitis atopy Patients treat exacerbation 1 Mo prior screen Patients treat noncardioselective βblockers Patients treat longacting antihistamine Known respiratory disorder COPD Patients clinically significant cardiovascular condition</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Frequent exacerbators</keyword>
</DOC>